Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

221
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
221
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

213
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
213
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

312
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
312
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

People with prior tuberculosis have accelerated frailty and differential survival into older age: a cross-sectional analysis in Southern Africa.

The Journal of infectious diseases·2026
Same author

Persistent evidence practice gap in antibiotic use for community acquired pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Pregnancy data in tuberculosis surveillance: Practices, priorities and perspectives from national TB programs in the Western Pacific and South-East Asia.

Public health·2026
Same author

Tuberculosis research principles and priorities in children and adolescents: an international consensus statement.

The Lancet. Child & adolescent health·2026
Same author

Molecular diagnostic tests for isoniazid-resistant tuberculosis: a scoping review.

The Lancet. Microbe·2026
Same author

Whole genome sequencing for Mycobacterium tuberculosis in public health responses: a review of current practice and enablers in select low-incidence jurisdictions.

BMC public health·2026

Related Experiment Video

Updated: Jun 11, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K

Community-Wide Active Case Finding for Tuberculosis: Time to Use the Evidence We Have.

Mikaela Coleman1,2, Chris Lowbridge3, Philipp du Cros4,5

  • 1Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW 2050, Australia.

Tropical Medicine and Infectious Disease
|September 27, 2024
PubMed
Summary

Community-wide active case finding for tuberculosis (Mycobacterium tuberculosis) is crucial for high-incidence areas. Implementing this strategy locally, with tailored research, is key to reducing transmission and advancing elimination efforts.

Keywords:
TBactive case findingcommunity-wideeliminationpopulation-widesystematic screeningtuberculosis

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

Related Experiment Videos

Last Updated: Jun 11, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a significant global health threat, particularly in high-incidence settings.
  • Current World Health Organization recommendations advocate for community-wide active case finding in these areas, yet uptake is limited.
  • Despite evidence of effectiveness, barriers to implementing TB active case finding persist in communities most at risk.

Purpose of the Study:

  • To analyze the complexities of TB elimination from fundamental principles.
  • To advocate for community-wide active case finding as the optimal strategy for high-incidence settings.
  • To emphasize the need for shifting research and funding towards local implementation and operational research.

Main Methods:

  • Review of TB elimination principles and current challenges.
  • Analysis of the effectiveness and implementation barriers of active case finding strategies.
  • Consideration of epidemiological and spatiosocial characteristics of high-incidence communities.

Main Results:

  • Community-wide active case finding is identified as the most effective current strategy for TB elimination in high-incidence settings.
  • Lack of uptake of this strategy hinders progress despite its proven benefits in reducing transmission.
  • Variability in community epidemiology necessitates tailored local implementation and operational research.

Conclusions:

  • Immediate implementation of community-wide active case finding is essential for accelerating TB elimination.
  • Research and funding must prioritize supporting local implementation, optimizing practices based on community-specific knowledge.
  • Focusing on local operational research will accelerate reductions in community-level TB transmission.